微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 5.45% | -10.95% | 59.36% | 19/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | 3.42% | 11.04% | -6.56% | 14/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 3.66% | -67.7% | -63.4% | 64/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 10% | 10.13% | 63.4% | 17/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 6.12% | 11.88% | 98.7% | 19/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 3.08% | 12.82% | -72.82% | 21/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 11.33% | 11.63% | 24.78% | 19/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 9.08% | 10.46% | 66% | 23/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 5.47% | 15.89% | 100.37% | 31/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 2.73% | -8.39% | -73.1% | 33/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 10.15% | 14.43% | 23.48% | 31/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 8.22% | -2.61% | 74.15% | 41/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 4.72% | 2.61% | 58.39% | 48/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 2.98% | 23.14% | -66.4% | 45/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 8.87% | 2.78% | 5.09% | 71/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 8.44% | 18.87% | 83.48% | 64/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 4.6% | 26.37% | 90.08% | 72/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 2.42% | 22.22% | -71.96% | 64/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 8.63% | -39.14% | 21.55% | 90/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 7.1% | -45.09% | 95.05% | 81/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 3.64% | -60.99% | 83.84% | 96/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 1.98% | 157.14% | -86.04% | 75/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 14.18% | 43.38% | 9.67% | 69/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 12.93% | 20.62% | 38.59% | 46/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 9.33% | 85.12% | 1111.69% | 47/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 0.77% | -63.33% | -92.21% | 61/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 9.89% | 52.86% | -7.74% | 79/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 10.72% | 129.06% | 112.7% | 26/141 | 10.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 5.04% | 113.56% | 140% | 44/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 2.1% | 204.35% | -67.54% | 31/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 6.47% | 2.7% | 38.25% | 83/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 4.68% | -22.26% | 98.31% | 39/141 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 2.36% | -38.7% | 242.03% | 48/141 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 0.69% | -59.88% | -89.05% | 46/141 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 6.3% | -17.11% | 4.65% | 79/141 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 6.02% | -19.41% | 56.36% | 33/141 | 9.49% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 3.85% | 7.24% | 123.84% | 39/141 | 6.11% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 1.72% | -4.44% | -77.37% | 32/141 | 2.74% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 7.6% | -27.34% | 1.74% | 62/141 | 16.44% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 7.47% | -27.97% | 108.08% | 20/141 | 8.86% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 3.59% | -28.63% | 99.44% | 33/141 | 6.35% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | 1.8% | -34.55% | -82.79% | 20/141 | 2.3% | 健帆生物 | 7.75% | 行业排名> |